In accordance with the "Pharmaceutical Administration Law of the People's Republic of China", the 2025 Edition of the "Pharmacopoeia of the People's Republic of China" (hereinafter referred to as the "Chinese Pharmacopoeia") has been reviewed and approved by the plenary session of the 12th Pharmacopoeia Committee Executive Committee. It is hereby promulgated and shall come into effect on October 1, 2025. The table of contents of the 2025 Edition of the "Chinese Pharmacopoeia" is attached.
This is to announce.
Attachment 1: Catalogue of the First Part of the 2025 Edition of the Chinese Pharmacopoeia
Attachment 2: Catalogue of the Second Part of the 2025 Edition of the Chinese Pharmacopoeia
Attachment 3: Catalogue of the Third Part of the 2025 Edition of the Chinese Pharmacopoeia
Attachment 4: Catalogue of the Fourth Part of the 2025 Edition of the Chinese Pharmacopoeia
National Medical Products Administration
National Health Commission
March 20, 2025